Literature DB >> 9689953

[Standard versus individually planned irradiation field in radiotherapy of infradiaphragmatic lymph node sites].

M Nevinny-Stickel1, S Ennemoser, I Bangerl, D zur Nedden, P Lukas.   

Abstract

PURPOSE: In prophylactic irradiation of infradiaphragmatic lymphatic nodes, the width of the paraaortic and pelvic field is given by a line joining the tips of the transverse processes of the 11th thoracic to the 4th lumbar vertebra from where the field boundary follows a straight line to the most lateral point of the acetabulum as seen in simulation film. Another way to build the field border is to project the lateral contours of the large abdominal vessels from T1-weighted coronal MR images of the abdomen on the simulator radiographs and add a 2-cm margin along the vessels delineated. In our study, we compared both methods as to full enclosure of paraaortic and pelvic lymphatics or nodal miss.
MATERIAL AND METHODS: Abdominal CT scans of 81 patients with involvement of paraaortic lymph node regions were examined with maximum lymph node sizes of 2.5 cm. The distance from the center of the appropriate vertebra to the lateral lymph node contour referring to the transverse process as well as to the outside contour of the aorta on the left and the vena cava on the right side, respectively, the iliac vessels were measured from T12 through S1. At the level of the hip joint the measurement point was given by the caput femoris.
RESULTS: Our measurement prove that 10% of the lymph nodes were found lateral from the transverse processes of the thoracic and lumbar vertebras and 12% outside the 2-cm safety margin from the lateral contour of the large abdominal vessels.
CONCLUSION: Our data show, that the customary fields for infradiaphragmatic lymphatic nodes have so far not been able to enclose all retroperitoneal and pelvic lymph nodes with certainty.

Entities:  

Mesh:

Year:  1998        PMID: 9689953     DOI: 10.1007/bf03038346

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  7 in total

1.  The radical radiotherapy of regionally localized Hodgkin's disease.

Authors:  H S KAPLAN
Journal:  Radiology       Date:  1962-04       Impact factor: 11.105

2.  Prophylactic irradiation of the para-aortic lymph node chain in stage IIB and bulky stage IB carcinoma of the cervix, initial treatment results of RTOG 7920.

Authors:  M Rotman; K Choi; C Guse; V Marcial; N Hornback; M John; C Guze
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-09       Impact factor: 7.038

3.  [Abdominal irradiation in seminomas: improvement in its planning with MRT].

Authors:  F B Zimmermann; P Lukas; M Molls
Journal:  Strahlenther Onkol       Date:  1996-06       Impact factor: 3.621

4.  [Is lymphography still relevant in seminoma?].

Authors:  M van Kampen; P Andreas; H Renner
Journal:  Strahlenther Onkol       Date:  1993-04       Impact factor: 3.621

5.  The role of paraaortic node irradiation in the treatment of cancer of the cervix.

Authors:  D Nori; E Valentine; B S Hilaris
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-08       Impact factor: 7.038

6.  Correlation of lymphangiography, computed tomography, and laparotomy in the staging of Hodgkin's disease.

Authors:  M D Sombeck; N P Mendenhall; J V Kaude; G M Torres; R R Million
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-02-15       Impact factor: 7.038

7.  Omission of the pelvic irradiation in stage I testicular seminoma: a study of postorchiectomy paraaortic radiotherapy.

Authors:  I C Kiricuta; J Sauer; W Bohndorf
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-05-01       Impact factor: 7.038

  7 in total
  1 in total

1.  [Possibilities of an open magnetic resonance scanner integration in therapy simulation and three-dimensional radiotherapy planning].

Authors:  K Schubert; F Wenz; R Krempien; O Schramm; G Sroka-Perez; P Schraube; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.